Related by context. All words. (Click for frequent words.) 74 pharmacokinetic characteristics 72 plasma pharmacokinetics 71 linear pharmacokinetics 70 paricalcitol 70 favorable pharmacokinetic profile 70 fosbretabulin 70 pharmacodynamic effects 70 pharmacodynamic parameters 70 analgesic efficacy 70 Pharmacokinetic 70 vitro cytotoxicity 69 AST ALT 69 pharmacokinetic interactions 69 viral kinetics 69 busulfan 68 S/GSK# 68 HCV replicon 68 Pharmacokinetic parameters 68 dosage regimens 68 metabolite concentrations 68 Teriflunomide 68 pharmacokinetic parameters 68 ALB # 68 radezolid 68 pharmacodynamic properties 68 alicaforsen enema 68 #beta estradiol 68 macrolide antibiotic 68 Non inferiority 68 Pharmacokinetic studies 68 Kahalalide F 68 tumorigenicity 68 riociguat 67 EDEMA3 trial 67 oral rivaroxaban 67 K ras mutations 67 maximally tolerated dose 67 pharmacokinetic PK profile 67 antiangiogenic activity 67 interleukin IL -# 67 pharmacokinetics PK 67 pyridostigmine 67 gadobutrol 67 clomipramine 67 5alpha reductase 67 CIMZIA ™ 67 ENMD # 67 antiviral potency 67 adrenal suppression 67 MAGE A3 ASCI 67 NATRECOR ® 67 Immunohistochemical analysis 67 pressor response 66 ZOLINZA 66 DAVANAT 66 selective modulator 66 galiximab 66 aminotransferases 66 ULORIC 66 hematological parameters 66 M1 muscarinic 66 pharmacokinetic pharmacodynamic 66 acoustic startle 66 relapsed MM 66 RRM1 66 SCIg 66 serum leptin 66 clevidipine 66 pentoxifylline 66 BENICAR HCT 66 antiviral efficacy 66 antitumor effect 66 dose proportional pharmacokinetics 66 preclinically 66 ritonavir boosted 66 Traficet EN 66 biodistribution 66 urinary N telopeptide 66 RE LY trial 66 insulin detemir 66 solithromycin 66 antiretroviral naive 66 pharmacodynamic profile 66 flavopiridol 66 Tasigna prolongs 66 E. faecalis 66 aplindore 66 DLTs 66 prospectively stratified 66 plasma lipoprotein 66 HER2 expression 66 Tumor Response 66 isoproterenol 66 Subgroup analyzes 66 zoledronate 66 intraobserver 66 corrected QT interval 66 Eligen R B# 66 lactate dehydrogenase LDH 66 somatostatin analog 66 APTIVUS r 66 isatoribine 66 pharmacokinetics pharmacodynamics 66 thyrotropin 66 PROCHYMAL 66 decitabine 66 serum antibody 66 pharmacokinetic equivalence 66 serum urate levels 66 GAMMAGARD 66 intact parathyroid hormone 66 florbetaben 66 IFN beta 66 achieved statistical significance 66 eosinophil count 66 Darinaparsin 66 hA# 65 bactericidal activity 65 basal bolus regimen 65 B7 H3 65 uricase 65 CLORETAZINE TM VNP#M 65 ESBA# 65 desvenlafaxine succinate 65 pharmacodynamic PD 65 serum concentrations 65 potentiation 65 antidepressant efficacy 65 GSK# [001] 65 LT NS# 65 CYT# potent vascular disrupting 65 plasma lipid 65 Pharmacokinetic PK 65 Capesaris 65 pharmacodynamic endpoints 65 genotypic resistance 65 QTc prolongation 65 coadministration 65 steroid dexamethasone 65 somatostatin 65 oral prodrug 65 receptor inhibitor 65 Virulizin ® 65 ADAGIO study 65 Subgroup analysis 65 preclinical efficacy 65 pharmacodynamic markers 65 PBMCs 65 abacavir lamivudine 65 QT QTc 65 immunostaining 65 CANCIDAS 65 milatuzumab 65 serum phosphate 65 antipsychotic efficacy 65 pharmacokinetic PK 65 racemic baclofen 65 pharmacokinetic profiles 65 clinically meaningful improvement 65 fumagillin nanoparticles 65 pharmacologically active isomer 65 inhaled iloprost 65 plasma leptin 65 vitamin B# folic acid 65 PSMA ADC 65 beta lactam antibiotic 65 antitumor efficacy 65 INVEGA ® 65 locomotor activity 65 FKBP# 65 Afatinib 65 hyperphenylalaninemia HPA due 65 prochlorperazine 65 vitro experiments 65 hemagglutination inhibition 65 cMET 65 Known hypersensitivity 65 demonstrated antitumor activity 65 TRAIL R1 65 aspartate aminotransferase 65 hematologic parameters 65 avosentan 64 antiresorptive 64 guanfacine 64 haematologic 64 GHRH 64 Hepatotoxicity 64 eculizumab therapy 64 serum calcium 64 HIF PH inhibitors 64 O PPDS 64 MP4OX 64 statistical significance p 64 tolerability profiles 64 dose dependently 64 histologic findings 64 Mg Uk 64 fluvastatin 64 gp# protein [002] 64 anticancer activity 64 prucalopride 64 pomalidomide 64 morphometric vertebral fractures 64 BEXXAR Therapeutic Regimen 64 ziconotide 64 rt PA 64 BMS# 64 Anticalins ® 64 APOPTONE 64 pharmacodynamics PD 64 Symptom severity 64 L PPDS 64 pharmacodynamic 64 serum phosphorous 64 immunohistochemical 64 intradermal injections 64 TNFalpha 64 LAB CGRP 64 Enzastaurin 64 tipranavir 64 hemostatic efficacy 64 multiple logistic regression 64 β blockers 64 serum cortisol 64 caspofungin 64 Pharmacodynamics 64 preclinical pharmacokinetic 64 conventional DMARDs 64 NPH insulin 64 carcinoembryonic antigen 64 flecainide 64 rHuPH# 64 D aspartate NMDA receptor 64 microdose 64 mesalamine granules 64 cisplatin gemcitabine 64 Privigen 64 plasma kallikrein inhibitor 64 teriflunomide 64 left ventricular diastolic 64 vismodegib 64 Histologic 64 lymphocyte counts 64 levodopa induced dyskinesia 64 Aldosterone 64 intermittent dosing 64 bovine thrombin 64 alefacept 64 tacrolimus ointment 64 safety tolerability pharmacokinetic 64 antitumour activity 64 thyroglobulin 64 lactate dehydrogenase 64 trastuzumab Herceptin ® 64 telomerase inhibition 64 guanfacine extended release 64 liposome formulation 64 aldosterone antagonist 64 ORMD 64 Zevalin consolidation 64 VAPRISOL 64 human chorionic gonadotropin hCG 64 FFNS 64 TRAIL R2 64 GLYX 64 cardiac repolarization 64 budesonide foam 64 glomerular filtration 64 immunological responses 64 Pharmacodynamic 64 ALA PDT 64 insulin lispro 64 MYCAMINE 64 darunavir ritonavir 64 intranasally administered 64 posaconazole 64 MAS XR 64 glycosylated hemoglobin HbA1c 64 Multivariate logistic regression 64 lanthanum carbonate 64 oral FTY# 64 bronchodilation 64 imexon 64 INCB# [003] 64 mg kg BID 64 thorough QT 64 sorafenib tablets 64 culture supernatants 64 metastatic neuroendocrine tumors 63 serum retinol 63 serum estradiol 63 azilsartan medoxomil 63 bezafibrate 63 Ceplene/IL-2 63 liposomal doxorubicin 63 dnaJP1 63 pituitary hormone 63 samalizumab 63 lesional 63 hypericin 63 pathophysiological effects 63 ursodeoxycholic acid 63 hMG 63 Zemplar Capsules 63 antiangiogenic therapy 63 CCX# 63 CDK inhibitor 63 novel VDA molecule 63 antiandrogens 63 IGFBP 3 63 interferon alfa 2b 63 evaluating tivozanib 63 serum urate 63 aminotransferase levels 63 vasoactive 63 Mg Usa 63 Pemetrexed 63 dose escalation phase 63 pegylated liposomal doxorubicin 63 radiolabeled TM# 63 pleiotropic effects 63 XL# inhibits 63 Symadex 63 fulvestrant 63 HuMax EGFr 63 BAL# [002] 63 follicular fluid 63 serum calcium levels 63 subcutaneously administered 63 indibulin 63 umbilical vein 63 intravenous dosing 63 pharmacokinetic PK study 63 FOSRENOL ® 63 symptomatic VTE 63 intravenous immunoglobulin IVIg 63 masitinib 63 FDG PET imaging 63 differential gene expression 63 rhEPO 63 IgG antibody 63 IOP lowering 63 Antitumor Activity 63 Methylnaltrexone 63 tetracycline antibiotic 63 GLP1 agonist 63 NB S# strontium malonate 63 apolipoprotein A1 63 strontium ranelate 63 systemic bioavailability 63 siRNA knockdown 63 Akt activation 63 amprenavir 63 APTIVUS 63 weekly subcutaneous injections 63 1mg 2mg 63 delafloxacin 63 potent antitumor activity 63 transaminase elevations 63 insulin degludec 63 HMG CoA reductase inhibitors 63 platelet inhibition 63 liposomal formulation 63 nonnucleoside reverse transcriptase inhibitors 63 doxorubicin cyclophosphamide 63 Plasmin 63 alkaline phosphatase ALP 63 CYP#C# genotype 63 canakinumab 63 REMINYL ® 63 hepatotoxic 63 CYT# QbG# 63 pharmacodynamic profiles 63 Primary endpoints 63 CINQUIL 63 potent anti angiogenic 63 Brief Psychiatric 63 cardioprotective effects 63 serum BDNF 63 blinded randomized placebo controlled 63 reactogenicity 63 mITT population 63 fosamprenavir 63 serum lipid 63 latanoprost 63 iloprost 63 prostanoid 63 CIMZIA TM 63 subcutaneous SC 63 PREZISTA r 63 lispro 63 colesevelam 63 atazanavir ritonavir 63 human Chorionic Gonadotropin 63 remifentanil 63 FOLPI 63 ketorolac 63 urate lowering 63 maximal tolerated 63 5 HT2C receptor 63 inhibin B 63 murine model 63 nanomolar 63 Amphinex ® 63 cannabinor 63 GFT# 63 interferon IFN 63 Triapine R 63 systemically administered 63 KB# [002] 63 heparanase 63 RSD# oral 63 immunomodulation 63 oxcarbazepine 63 elevated ALT 63 biochemical abnormalities 63 serum IgG 63 CIMZIA R 63 reduce serum phosphate 63 elevated creatinine 63 factor Xa 63 nelfinavir 63 randomized multicenter trial 63 tolerability pharmacokinetics 63 Meta analyzes 63 redox active 63 ImmunoVEX HSV2 63 Ophena TM 63 pramlintide metreleptin combination 63 XR NTX 63 dose Iluvien 63 opioid naïve 63 Degarelix 63 #F FDG PET 63 liver transaminases 63 tumor xenograft models 63 icatibant 63 agonist antagonist 63 vidofludimus 63 NAbs 63 SPIRIVA HandiHaler 63 BoNTA 63 TIMP 1 63 pain palliation 63 LEXIVA r 63 ß carotene 63 probiotic supplementation 63 PPARgamma 63 mg Pycnogenol 63 HepG2 cells 63 ginkgo extract 63 Tolvaptan 63 bortezomib Velcade 63 Neuropsychiatric Inventory NPI 63 MVA MUC1 IL2 62 hemagglutination inhibition HAI 62 pegylated IFN 62 serum homocysteine 62 mononuclear 62 airway responsiveness 62 ARIKACE 62 papillary renal cell carcinoma 62 F FDG uptake 62 urocortin 2 62 IFN α 62 Randomized Double blind 62 tegaserod 62 ACTEMRA TM 62 SGPT 62 #ß 62 physiologically relevant 62 wilate ® 62 intensive lipid lowering 62 plasma cortisol 62 cefotaxime 62 pan HDAC inhibitor 62 antiapoptotic 62 CD# expression [002] 62 interobserver 62 tolvaptan 62 metreleptin 62 sulfasalazine 62 fusion enhancers 62 Multiple logistic regression 62 meropenem 62 convergent validity 62 transaminases 62 dopamine partial agonist 62 PASI scores 62 5 HT1A receptor 62 tigecycline 62 peripheral blood mononuclear 62 nicardipine 62 aminobutyric acid 62 renal toxicity 62 #mg doses [002] 62 Linagliptin 62 ziprasidone 62 enzyme inhibition 62 Cariprazine 62 selenium supplementation 62 ^ sup #m 62 MERLIN TIMI 62 Fulvestrant 62 clinicopathological 62 oral picoplatin 62 cardiac troponin T 62 placebo controlled clinical trials 62 TACI Ig 62 urodynamic 62 serum phosphate levels 62 ultrastructural 62 immune modulatory 62 ANAVEX #-# [002] 62 C telopeptide 62 meta regression 62 lenalidomide dexamethasone 62 glycated hemoglobin levels 62 Interferon alpha 62 #I TM# 62 AGHD 62 hsCRP levels 62 MGd 62 EUFLEXXA R 62 hyperalgesia 62 transdermal estradiol 62 nanomolar range 62 FUSILEV enhances 62 GH deficiency 62 peak plasma concentrations 62 CPAP adherence 62 triglyceride concentrations 62 zotarolimus 62 serum lipid levels 62 metaanalysis 62 immunohistochemical analysis 62 topically administered 62 #mg dose [001] 62 certolizumab 62 bolus dose 62 dosing interval 62 CIMZIA TM certolizumab pegol 62 Tarceva TM 62 prasterone 62 AAG geldanamycin analog 62 mGluR5 NAM 62 gallium nitrate 62 Omacetaxine mepesuccinate 62 seroprotection 62 scintigraphic 62 5 HT2A 62 sequestered naltrexone 62 effector function 62 intravenous bolus 62 Cochrane reviewers 62 Aclidinium 62 tipranavir r 62 edifoligide 62 Apoptone 62 inflammatory biomarkers 62 Multivariate analysis 62 ancrod 62 conditional logistic regression 62 inotropic agents 62 Androxal TM 62 hyperinsulinemic euglycemic clamp 62 alpha 2a 62 Fondaparinux 62 quetiapine Seroquel 62 alvespimycin 62 HIF 1a 62 Cathepsin B 62 Aflibercept 62 See CLINICAL PHARMACOLOGY 62 ibandronate 62 Seliciclib 62 Tumor regression 62 YONDELIS 62 t# c# CLA 62 DCCR 62 pegylated alpha interferon 62 T1 weighted images 62 antiepileptics 62 colorectal adenoma 62 serum biomarkers 62 immunomodulatory agents 62 saline placebo 62 anti leukemic 62 STAT3 activation 62 Cardiorespiratory fitness 62 CK # administered 62 parathyroid hormone PTH 62 budesonide pMDI 62 intra tumoral 62 CorVue ™ 62 apolipoproteins 62 cefazolin 62 virologic 62 irbesartan 62 potency selectivity 62 mCi 62 Leydig cells 62 CYP#A# CYP#D# 62 rFVIIa 62 serotonin synthesis 62 double blinded placebo 62 MET amplification 62 Vildagliptin 62 MIRCERA 62 Hypertensive adverse reactions 62 reticulocytes 62 retapamulin 62 enfuvirtide 62 PEG SN# 62 platelet dysfunction 62 antibody titer 62 serum antibodies 62 BPS IC 62 GAMMAGARD LIQUID 62 otamixaban 62 hepatic enzymes 62 HIV RNA 62 Cardiotoxicity 62 eszopiclone 62 octreotide acetate 62 Helicobacter infection 62 liposomal amphotericin B 62 virological response 62 mecamylamine 62 concomitantly administered 62 colorectal adenocarcinoma 62 intracellular uptake 62 nonrandomized 62 cardioprotection 62 bicalutamide 62 mg kg dose 62 Thiovir 62 severe hypersensitivity reactions 62 oncologic outcomes 62 orally administered inhibitor 62 CD#c 62 GRNCM1 62 OMP #M# 62 everolimus eluting stents 62 transgene expression 62 maximal doses 62 hydroxy vitamin D 62 AXIRON ™ 62 PEGylated anti 62 anaphylactic reactions bronchospasm 62 EGFR HER2 62 virologic responses 62 cobalamin 62 db db mice 62 INTEGRILIN R 62 potent inhibition 62 sitaxsentan 62 ONGLYZA saxagliptin 62 immunofluorescence microscopy 62 unconjugated 62 Perforomist ™ Inhalation Solution 62 IFN γ 62 #mg dose [002] 62 idarubicin 62 intravenous bisphosphonates 62 gastrointestinal absorption 62 efficacy tolerability 62 granisetron 62 pioglitazone HCl 62 Pharmacokinetics PK 62 Tekamlo 62 HYLENEX recombinant 62 antisense inhibition 62 immune modulating 62 perfusion MRI 62 favorable pharmacokinetic 62 tumor histology 62 active comparator 62 IgG1 antibodies 62 Aeolus Pharmaceuticals Announces 62 metabolomic profiles 62 orally inhaled 62 alpha7 62 antiproliferative effects 62 DuraSite 62 FUS1 62 Preclinical Study 62 myocardial necrosis 62 HuR 62 crizotinib PF # 62 Azedra 62 Cyclin E 62 STRIDE PD 62 histone deacetylase inhibitor 62 dosed orally 62 Perforomist Inhalation Solution 62 ceftazidime 62 mg RDEA# 62 ACh 62 CBLC# 62 infantile colic 62 KAPIDEX 62 nitrofurantoin 62 GH secretion 62 mg/m2 cohort 62 electrophysiologic 62 dosing cohort 62 trials RCTs 62 Immunohistochemical 62 immunoglobulin G 62 serum uric acid 62 cAMP signaling 62 MBq 62 #mg/day [002] 62 clinically meaningful differences 62 EDEMA3 62 humanised monoclonal antibody 62 Serum potassium 62 enzyme immunoassay EIA 62 radiation dosimetry 62 lactulose 62 Oral NKTR 61 NS5B polymerase 61 antiarrhythmic 61 dosing frequency 61 radiographic outcomes 61 JAK inhibitors 61 Bystolic nebivolol 61 clinically meaningful improvements 61 PET tracers 61 sulodexide 61 DermaVir 61 RoACTEMRA 61 histone acetylation 61 rhIGFBP 3 61 TMPRSS2 ERG fusion 61 complete cytogenetic response 61 CorVue TM 61 Ziprasidone 61 radiolabeled 61 mapatumumab 61 posttreatment 61 cardiac autonomic 61 ACCORD Lipid 61 chlamydial 61 colorectal liver metastases 61 Valproic acid 61 bronchodilatory 61 FDG uptake 61 P selectin 61 administered subcutaneously 61 colesevelam HCl 61 peptide antigens 61 griseofulvin 61 Acute Ischemic Stroke 61 aldosterone antagonists 61 antimuscarinic 61 SPIRIVA R 61 paroxetine sertraline 61 ON #.Na 61 alanine aminotransferase ALT 61 AMACR 61 headache nasopharyngitis 61 alfuzosin 61 HQK 61 anti amnesic 61 dose limiting toxicities 61 opioid mediated 61 bronchoalveolar lavage 61 EDARBI 61 symptom exacerbation 61 radioimmunoassay 61 RSD# 61 metaplasia 61 Arikace 61 CYP#A# substrate 61 intracoronary 61 Venlafaxine 61 biologic DMARD 61 octreotide LAR 61 cediranib 61 Creatinine 61 Serdolect ® 61 SNP rs# [002] 61 estramustine 61 miglustat 61 leflunomide 61 Orthostatic hypotension 61 PRADAXA 61 mTOR inhibition 61 bleomycin 61 Blinatumomab 61 antitumor effects 61 intratumoral 61 Hedgehog inhibitor 61 Hematologic toxicity 61 EXJADE 61 isotype 61 convenient dosing regimens 61 apolipoprotein B 61 PTHrP 61 serum phosphorus 61 Ophena 61 Lp PLA 2 61 aspirin clopidogrel 61 venlafaxine XR 61 cefuroxime 61 prostate carcinoma 61 midstage clinical 61 glycated hemoglobin HbA1c 61 Zoraxel 61 GOUT 61 kilogram mg kg 61 naltrexone SR 61 cTnI 61 timepoints 61 Anticalins R 61 SUSTENNA TM 61 davunetide intranasal AL 61 intestinal permeability 61 pegylated interferon alfa 61 Belerofon 61 Xelox 61 daily subcutaneous injections 61 GLUT4 61 CYP#D# inhibitors 61 DACH platinum 61 concurrent chemoradiation 61 anxiolytic 61 bepotastine besilate nasal spray 61 Insulin sensitivity 61 Akathisia 61 glucocorticoid receptors 61 opioid naive 61 Imprime PGG 61 lanreotide 61 CTAP# Capsules 61 intima media thickness IMT 61 #ME# 61 therapeutically relevant 61 INVEGA ™ 61 Aggrastat ® tirofiban hydrochloride 61 vapreotide acetate 61 spirometric 61 hepatoma 61 zonisamide SR 61 adrenocorticotropic hormone 61 flutamide 61 5mg dose 61 solifenacin 61 Atomoxetine 61 antioxidant supplementation 61 R roscovitine 61 torsemide ER 61 atorvastatin #mg 61 TPMT 61 autoregulation 61 alteplase 61 Doxil ® 61 epoetin alpha 61 Antitumor 61 ATACAND 61 stoichiometry 61 Bifidobacterium infantis # 61 picomolar 61 #mg/day [001] 61 Cethromycin 61 ventricular myocardium 61 exendin 4 61 CTA# 61 mediated inhibition 61 hENT1 61 dihydroergotamine 61 elastase 61 9mg 61 indinavir 61 imatinib therapy 61 HGS ETR1 mapatumumab 61 oral bioavailability 61 docetaxel Taxotere ® 61 C1 INH 61 lucinactant 61 IL #p# 61 fluticasone furoate 61 nucleoside analog 61 DAPT 61 Undesirable alterations 61 HCV protease inhibitors 61 KNS # 61 coagulation parameters 61 protease inhibitor PI 61 xenograft models 61 serum testosterone 61 chest radiographs 61 inert placebo 61 immunoreactivity 61 Iloperidone 61 specific IgE 61 ImmuKnow 61 pimecrolimus 61 sorafenib Nexavar 61 β carotene 61 administered intramuscularly 61 adenosine injection 61 Gamunex C 61 cardiac glycoside 61 TRIOLEX 61 Hypotension 61 biostatistical analysis 61 salivary cortisol 61 analgesic effects 61 tapentadol ER 61 CC genotype 61 biodistribution studies 61 dopamine D2 61 A3 adenosine receptor 61 intravascular hemolysis 61 teduglutide 61 QD dosing 61 Vidaza azacitidine 61 nab paclitaxel 61 serum HBV DNA 61 protein tyrosine phosphatase 1B 61 SERCA2a 61 pyrazinamide 61 Histopathological 61 R# #mg BID 61 myopathy rhabdomyolysis 61 Rigorous scientific 61 SYN# 61 Sym# 61 Moli# 61 airway hyperresponsiveness 61 multicenter Phase III 61 placebo controlled dose escalation 61 platelet inhibitor 61 ARIKACE ™ 61 multicenter trials 61 allergic airway inflammation 61 Intravail R 61 proteoglycan 61 microdialysis 61 #HT#A 61 EOquin TM 61 IV bisphosphonates 61 denileukin diftitox 61 tylosin 61 tipranavir ritonavir 61 rhITF 61 Dehydroepiandrosterone 61 experimentally induced 61 radioligand 61 CA4P 61 recurrent glioblastoma multiforme 61 Descriptive statistics 61 laropiprant 61 creatine supplementation 61 nitazoxanide 61 p# biomarker 61 integrin expression 61 AGILECT R 61 glulisine 61 APTIVUS ritonavir 61 LATUDA 61 XmAb# 61 Orthokine 61 β1 61 trans palmitoleate 61 Sudhir Agrawal D.Phil 61 racemic 61 TLR9 mediated immune 61 tryptase 61 CLA supplementation 61 Glufosfamide 61 tapentadol IR 61 maximal dose 61 Gilead Viread 61 silico prediction 61 inhaled budesonide 61 hepatic fibrosis 61 F FDG PET 61 MVax 61 serum TSH 61 efalizumab 61 Solulin 61 moderate hepatic impairment 61 imatinib resistant 61 Dabigatran etexilate 61 Tyrima 61 Histologically 61 neurophysiologic 61 Multivariate analyzes 61 Vidofludimus 61 stavudine d4T 61 EVIZON 61 Valortim ® 61 L lysine 61 weekly intravenous infusions 61 PD LID